Key Laboratory of Marine Drugs, The Ministry of Education of China, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, China.
Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, College of Chemistry and Chemical Engineering, Hainan Normal University, Haikou 571158, China.
Mar Drugs. 2024 Sep 25;22(10):431. doi: 10.3390/md22100431.
The incidence of infection is on the rise; however, the existing drug treatment cycle is lengthy and often requires multi-drug combination. Therefore, there is a need to develop new and effective anti- drugs. Cochliomycin A, a 14-membered resorcylic acid lactone with an acetonide group at C-5' and C-6', exhibits a wide range of antimicrobial, antimalarial, and antifouling activities. To further explore the effect of this structural change at C-5' and C-6' on this compound's activity, we synthesized a series of compounds with a structure similar to that of cochliomycin A, bearing ketal groups at C-5' and C-6'. The / configuration of the diastereoisomer at C-13' was further determined through an NOE correlation analysis of CH or CH at the derivative C-13' position and the H-5' and H-6' by means of a 1D NOE experiment. Further comparative H NMR analysis of diastereoisomers showed the difference in the chemical shift () value of the diastereoisomers. The synthetic compounds were screened for their anti-microbial activities in vitro. Compounds - and - demonstrated promising activity against , with MIC values ranging from 70 to 90 μM, closely approaching the MIC of isoniazid. The preliminary structure-activity relationships showed that the ketal groups with aromatic rings at C-5' and C-6' could enhance the inhibition of . Further study demonstrated that compounds , , , and had significant inhibitory effects on and addictive effects with isoniazid and rifampicin. Its effective properties make it an important clue for future drug development toward combatting resistance.
感染的发病率正在上升;然而,现有的药物治疗周期较长,通常需要多种药物联合使用。因此,需要开发新的、有效的抗药性药物。Cochliomycin A 是一种含有乙酰内酯基的 14 元环缩酚酸内酯,在 C-5' 和 C-6' 位具有酮缩醇基,具有广泛的抗菌、抗疟和抗污活性。为了进一步探讨 C-5' 和 C-6' 位的这种结构变化对该化合物活性的影响,我们合成了一系列与 Cochliomycin A 结构相似的化合物,在 C-5' 和 C-6' 位具有缩酮基。通过 1D NOE 实验对 C-13' 位衍生物的 CH 或 CH 与 H-5' 和 H-6' 之间的 NOE 相关分析,进一步确定了 C-13' 位的非对映异构体的 / 构型。进一步对非对映异构体的比较 1 H NMR 分析表明,非对映异构体的化学位移()值存在差异。对合成化合物进行了体外抗微生物活性筛选。化合物 - 和 - 对 表现出有希望的活性,MIC 值范围为 70 至 90 μM,接近异烟肼的 MIC。初步的结构-活性关系表明,C-5' 和 C-6' 位具有芳环的缩酮基可以增强对 的抑制作用。进一步的研究表明,化合物 、 、 、 对 和 具有显著的抑制作用,与异烟肼和利福平有协同作用。其有效特性使其成为未来开发抗 耐药性药物的重要线索。